Skip to main content
. 2017 Nov 13;7:15441. doi: 10.1038/s41598-017-14843-6

Figure 3.

Figure 3

MiR-23b cluster and miR-125a-5p induce drug sensitivity in NSCLC cell lines. (a,b) Enforced expression of miR-23b, miR-24, miR-27b and miR-125a-5p in A549 cells reduced cell proliferation after cisplatin treatment. (c,d) Enforced expression of miR-23b, miR-24, miR-27b and miR-125a-5p in A549 and H1299 cells decreased cell proliferation after cisplatin or TRAIL treatment. (e) Overexpression of miR-23b, miR-24 and miR-27b increased apoptosis after cisplatin treatment in A549 cells, whereas miR-125a-5p had no effect. (f) Cells stably expressing miR-23b cluster are more sensitive to cisplatin compared to control cells, as assessed by Annexin V. Error bars indicate mean ± SD (n = 3). *p < 0.05, **p < 0.01 by two-tailed Student’s t test.